Norris Medicines Ltd

NSE: NORRIS · BSE: 524414 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹15.58
Market cap: ₹15.58 Cr
Revenue (annual): ₹8.13 Cr
Net profit (annual): ₹-0.28 Cr
P/E (TTM): -42.5×Sector 47.3×
Promoter holding: 34.01%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Board Meeting Date 2 Other Announcement 1 Management Change 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

8 Aug 2026 14:56 IST BSE

Board Meeting Date

Norris Medicines Board Meeting Date

Norris Medicines Limited has scheduled a board meeting for August 14, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.

Read the filing ↗

25 May 2026 19:39 IST BSE

Board Meeting Date

Norris Medicines Board Meeting Date

Norris Medicines scheduled a board meeting for May 30, 2026, to approve audited FY26 financial results. The trading window remains closed until 48 hours post-declaration.

Read the filing ↗